{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:57:25Z","timestamp":1781643445522,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Res Involv Engagem"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>EUPATI Spain and EURORDIS have implemented a patient engagement model in health product research and development (R&amp;D): international, independent Community Advisory Boards (CABs), where patients collaborate with health product companies in patient-led CAB meetings. We have evaluated the methodology of these CAB meetings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a mixed-methods cross-sectional survey study from 2022 to 2023 to analyze the satisfaction level and perceived usefulness of CAB meetings between CAB members and company representatives across 15 CAB meetings. After each meeting, participants received an online survey comprising ten closed-ended questions on a five-point Likert scale and two open-ended questions about key takeaways and issues to improve. Written responses to open-ended questions were analyzed by AI-assisted ATLAS.ti, which categorized and quantified them semantically, and by contextual relevance and frequency. Characteristics of meetings and participants were reported, and survey responses were compared between CAB members and company representatives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most meetings were hybrid (53.3%). A total of 252 participants attended the meetings (158 [62.7%] CAB members, 94 [37.3%] company representatives). The overall survey response rate was 54.8%, 59.5% among CAB members and 46.8% among company representatives. Most participants found the meetings useful (86.0% CAB, 93.2% company), were satisfied with the topics addressed (77.4% CAB, 93.2% company), and met their expectations (76.7% CAB, 93.2% company). Both groups considered that the company understood the CAB\u2019s point of view (80.2% CAB, 90.9% company). Still, only 59.3% of CAB members thought the company would reconsider its plans, vs. 88.6% of company representatives. The three main takeaway areas were \u201cCollaboration and Partnerships\u201d, \u201cStudy Design and Protocols\u201d, and \u201cCommunication and Education\u201d. The main issue to improve was \u201cMeeting Organization and Structure\u201d.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, the satisfaction level and perceived usefulness of the CAB meetings were favorable. CAB members exhibited less favorable responses to all closed-ended questions than company representatives, especially regarding the possible influence on company actions. The open-ended responses reflected higher levels of agreement and collaboration, supporting the CAB model\u2019s potential. Some issues, mainly related to meeting organization and the hybrid format, need improvement. Future studies are required to assess the actual impact of CAB meetings on R&amp;D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Plain English summary<\/jats:title>\n                    <jats:p>EUPATI Spain and EURORDIS have implemented a patient engagement model in health product research and development: Community Advisory Boards (CABs). CABs are international, independent groups of patient representatives selected by their community who meet regularly with health product companies to discuss a wide range of topics, from study design to compassionate use of therapies. We have analyzed the satisfaction level and perceived usefulness of CAB meetings for CAB members and company representatives who attended 15 CAB meetings from 2022 to 2023, using a seven-minute online survey after each meeting. The survey included ten closed-ended questions and two open-ended questions on key takeaways and issues to improve. The feedback was highly positive. Most participants found the meetings useful, were satisfied with the topics addressed, and met their expectations. However, CAB members exhibited slightly less favorable responses to all closed-ended questions than company representatives, especially regarding the influence of CAB meetings on future company actions. The three main takeaway areas were \u201cCollaboration and Partnerships\u201d, \u201cStudy design and Protocols\u201d, and \u201cCommunication and Education\u201d; and the main issue to improve was \u201cMeeting Organization and Structure\u201d. Overall, the results were favorable. Although the closed-ended questions showed less confidence among CAB members on the future influence of the meetings, the comments from the open-ended questions reflected higher levels of agreement and collaboration and supported our CAB model\u2019s potential. Some issues, mainly related to meeting organization and the hybrid format, need improvement. Future studies are required to assess the actual impact of CAB meetings on companies\u2019 actions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40900-026-00866-9","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:16:16Z","timestamp":1773990976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the methodology of independent Community Advisory Boards in health products research and development: a mixed-methods cross-sectional survey study"],"prefix":"10.1186","volume":"12","author":[{"given":"Rob","family":"Camp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"DeKeyser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Leijenhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsharif","family":"Nasrulloeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Trigos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Hou\u00ffez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"866_CR1","unstructured":"European Medicines Agency (EMA). Patients and consumers [Internet]. cited 2025 Feb 16. Available from https:\/\/www.ema.europa.eu\/en\/partners-networks\/patients-consumers ."},{"key":"866_CR2","unstructured":"FDA. Evolution of patient engagement at the FDA [Internet]. cited 2025 Feb 16. Available from https:\/\/www.fda.gov\/patients\/evolution-patient-engagement-fda ."},{"issue":"3","key":"866_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40290-021-00388-7","volume":"35","author":"A Patel","year":"2021","unstructured":"Patel A, Fiebig D, Muszka J. The utility of patient engagement in Drug research and development. Pharm Med. 2021;35(3):157\u201362.","journal-title":"Pharm Med"},{"issue":"6","key":"866_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jval.2020.01.019","volume":"23","author":"RL Harrington","year":"2020","unstructured":"Harrington RL, Hanna ML, Oehrlein EM, Camp R, Wheeler R, Cooblall C, et al. Defining patient engagement in research: results of a systematic review and analysis: report of the ISPOR patient-Centered special interest group. Value Health. 2020;23(6):677\u201388.","journal-title":"Value Health"},{"key":"866_CR5","doi-asserted-by":"publisher","first-page":"811855","DOI":"10.3389\/fmed.2021.811855","volume":"8","author":"A Murphy","year":"2022","unstructured":"Murphy A, Bere N, Vamvakas S, Mavris M. The added Value of patient engagement in Early Dialogue at EMA: scientific advice as a case study. Front. Med. 2022;8:811855.","journal-title":"Front. Med"},{"issue":"1","key":"866_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s43441-023-00573-7","volume":"58","author":"N Bertelsen","year":"2023","unstructured":"Bertelsen N, Dewulf L, Ferr\u00e8 S, Vermeulen R, Schroeder K, Gatellier L, et al. Patient engagement and patient experience data in regulatory review and health technology assessment: a Global landscape review. Ther Innov Regul Sci. 2023;58(1):63.","journal-title":"Ther Innov Regul Sci"},{"issue":"9","key":"866_CR7","doi-asserted-by":"publisher","first-page":"103702","DOI":"10.1016\/j.drudis.2023.103702","volume":"28","author":"FI Auwal","year":"2023","unstructured":"Auwal FI, Copeland C, Clark EJ, Naraynassamy C, McClelland GR. A systematic review of models of patient engagement in the development and life cycle management of medicines. Drug Discov. Today. 2023;28(9):103702.","journal-title":"Drug Discov. Today"},{"key":"866_CR8","unstructured":"EMA. Engagement-framework-european-medicines-agency-and-patients-consumers-and-their-organisations_en [Internet]. cited 2025 Mar 27]. Available from https:\/\/www.ema.europa.eu\/en\/documents\/other\/engagement-framework-european-medicines-agency-and-patients-consumers-and-their-organisations_en.pdf ."},{"key":"866_CR9","unstructured":"FDA. FDA patient engagement overview [Internet]. cited 2025 Feb 16. Available from https:\/\/www.fda.gov\/patients\/learn-about-fda-patient-engagement\/fda-patient-engagement-overview ."},{"key":"866_CR10","doi-asserted-by":"crossref","unstructured":"Richards T, Scowcroft H, Doble E, Price A, Abbasi K. Healthcare decision making should be democratised. BMJ. 2021;373( n 1225).","DOI":"10.1136\/bmj.n1225"},{"issue":"3","key":"866_CR11","first-page":"523","volume":"23","author":"M Bird","year":"2020","unstructured":"Bird M, Ouellette C, Whitmore C, Li L, Nair K, McGillion MH, et al. Preparing for patient partnership: a scoping review of patient partner engagement and evaluation in research. Health Expect Int J Public Particip Health Care Health Policy. 2020;23(3):523\u201339.","journal-title":"Health Expect Int J Public Particip Health Care Health Policy"},{"issue":"1","key":"866_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40900-022-00364-8","volume":"8","author":"O Zvonareva","year":"2022","unstructured":"Zvonareva O, Crave\u021b C, Richards DP. Practices of patient engagement in drug development: a systematic scoping review. Res Involv Engagem. 2022;8(1):29.","journal-title":"Res Involv Engagem"},{"issue":"1","key":"866_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13023-025-03573-y","volume":"20","author":"J Pijuan","year":"2025","unstructured":"Pijuan J, Palau F. Patient involvement in clinical trials: a paradigm shift in research. Orphanet J Rare Dis. 2025;20(1):63.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"866_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40271-023-00648-5","volume":"17","author":"C Mease","year":"2024","unstructured":"Mease C, Fermaglich LJ, Jackler K, Shermer S, Miller KL. Determining commonalities in the experiences of patients with rare diseases: a qualitative analysis of US Food and Drug Administration patient engagement sessions. The Patient. 2024;17(1):25\u201337.","journal-title":"The Patient"},{"key":"866_CR15","unstructured":"Spain EUPATI. \u00bfQU\u00c9 ES EUPATI? [Internet]. cited 2025 Mar 29]. Available from https:\/\/eupati-es.org\/historia\/ ."},{"key":"866_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fmed.2018.00310","volume":"5","author":"P Spindler","year":"2018","unstructured":"Spindler P, Lima BS. Editorial: the European patients Academy on Therapeutic Innovation (EUPATI) guidelines on patient involvement in research and development. Front. Med. 2018;5:310.","journal-title":"Front. Med"},{"key":"866_CR17","unstructured":"EURORDIS. Who we are [Internet]. cited 2025 Mar 29]. Available from https:\/\/www.eurordis.org\/who-we-are\/our-vision-mission ."},{"key":"866_CR18","unstructured":"EURORDIS. EURORDIS Community Advisory Board Programme [Internet]. cited 2025 Mar 29]. Available from https:\/\/www.eurordis.org\/get-involved\/eurordis-community-advisory-board-programme\/ ."},{"issue":"1","key":"866_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.17294\/2330-0698.1859","volume":"9","author":"SE Fruytier","year":"2022","unstructured":"Fruytier SE, Vat LE, Camp R, Hou\u00ffez F, De Keyser H, Dunne D, et al. Monitoring and evaluation of patient engagement in health product research and development: Co-creating a framework for community advisory Boards. J Patient-Centered Res Rev. 2022;9(1):46\u201357.","journal-title":"J Patient-Centered Res Rev"},{"key":"866_CR20","unstructured":"PARADIGM. Community Advisory Boards [Internet]. cited 2025 Mar 29]. Available from https:\/\/imi-paradigm.eu\/petoolbox\/community-advisory-boards\/ ."},{"key":"866_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3389\/fmed.2018.00230","volume":"5","author":"D Haerry","year":"2018","unstructured":"Haerry D, Landgraf C, Warner K, Hunter A, Klingmann I, May M, et al. EUPATI and Patients in medicines research and development: guidance for patient involvement in regulatory processes. Front. Med. 2018;5:230.","journal-title":"Front. Med"},{"issue":"1","key":"866_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s43441-019-00034-0","volume":"54","author":"S Stergiopoulos","year":"2020","unstructured":"Stergiopoulos S, Michaels DL, Kunz BL, Getz KA. Measuring the impact of patient engagement and patient centricity in clinical research and development. Ther Innov Regul Sci. 2020;54(1):103\u201316.","journal-title":"Ther Innov Regul Sci"},{"key":"866_CR23","doi-asserted-by":"publisher","first-page":"1408636","DOI":"10.3389\/fmed.2024.1408636","volume":"11","author":"D Almeida","year":"2024","unstructured":"Almeida D, Umuhire D, Gonzalez-Quevedo R, Ant\u00f3nio A, Burgos JG, Verpillat P, et al. Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU. Front. Med. 2024;11:1408636.","journal-title":"Front. Med"},{"issue":"1","key":"866_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s40271-024-00713-7","volume":"18","author":"B Klein","year":"2025","unstructured":"Klein B, Perfetto EM, Oehrlein EM, Weston F, Lobban TCA, Boutin M. Measuring and demonstrating the Value of patient engagement across the medicines Lifecycle: a patient engagement impact measurement framework. The Patient. 2025;18(1):3\u201318.","journal-title":"The Patient"},{"issue":"3","key":"866_CR25","first-page":"1255","volume":"26","author":"J Abelson","year":"2023","unstructured":"Abelson J, Tripp L, MacNeil M, Lang A, Fancott C, Ganann R, et al. Development of the engage with impact toolkit: a comprehensive resource to support the evaluation of patient, family and caregiver engagement in health systems. Health Expect Int J Public Particip Health Care Health Policy. 2023;26(3):1255\u201365.","journal-title":"Health Expect Int J Public Particip Health Care Health Policy"},{"key":"866_CR26","doi-asserted-by":"publisher","first-page":"104946","DOI":"10.1016\/j.healthpol.2023.104946","volume":"138","author":"HJ Westerink","year":"2023","unstructured":"Westerink HJ, Oirbans T, Garvelink MM, van Uden-Kraan CF, Zouitni O, Bart HAJ, et al. Barriers and facilitators of meaningful patient participation at the collective level in healthcare organizations: a systematic review. Health Policy (New Y) Amst Neth. 2023;138:104946.","journal-title":"Health Policy (New Y) Amst Neth"},{"key":"866_CR27","unstructured":"European Commission. Rare diseases [Internet]. cited 2025 Dec 18]. Available from https:\/\/health.ec.europa.eu\/rare-diseases-and-european-reference-networks\/rare-diseases_en ."},{"key":"866_CR28","unstructured":"EURORDIS. What is a rare disease? [Internet]. cited 2025 Mar 30]. Available from https:\/\/www.eurordis.org\/information-support\/what-is-a-rare-disease\/ ."},{"issue":"5","key":"866_CR29","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1007\/s43441-021-00282-z","volume":"55","author":"M Cavaller-Bellaubi","year":"2021","unstructured":"Cavaller-Bellaubi M, Faulkner SD, Teixeira B, Boudes M, Molero E, Brooke N, et al. Sustaining meaningful patient engagement across the Lifecycle of medicines: a roadmap for action. Ther Innov Regul Sci. 2021;55(5):936\u201353.","journal-title":"Ther Innov Regul Sci"},{"key":"866_CR30","doi-asserted-by":"publisher","first-page":"108601","DOI":"10.1016\/j.pec.2024.108601","volume":"132","author":"M Wu","year":"2025","unstructured":"Wu M, Jia X, Zhang Y, Chen W. Towards better care: comprehensive review of patient-reported patient engagement instruments in healthcare. Patient Educ Couns. 2025;132:108601.","journal-title":"Patient Educ Couns"},{"key":"866_CR31","doi-asserted-by":"crossref","unstructured":"Eysenbach G. Improving the quality of web surveys: the checklist for reporting results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34.","DOI":"10.2196\/jmir.6.3.e34"},{"issue":"1","key":"866_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13643-019-0994-8","volume":"8","author":"TL McCarron","year":"2019","unstructured":"McCarron TL, Moffat K, Wilkinson G, Zelinsky S, Boyd JM, White D, et al. Understanding patient engagement in health system decision-making: a co-designed scoping review. Syst Rev. 2019;8(1):97.","journal-title":"Syst Rev"},{"issue":"3","key":"866_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1377\/hlthaff.2018.05067","volume":"38","author":"LP Forsythe","year":"2019","unstructured":"Forsythe LP, Carman KL, Szydlowski V, Fayish L, Davidson L, Hickam DH, et al. Patient engagement in research: early findings from the patient-Centered outcomes research institute. Health Aff (Millwood). 2019;38(3):359\u201367.","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"866_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/13645579.2015.1021949","volume":"19","author":"TM Paulus","year":"2016","unstructured":"Paulus TM, Lester JN. ATLAS.Ti for conversation and discourse analysis studies. Int J Soc Res Methodol. 2016;19(4):405\u201328.","journal-title":"Int J Soc Res Methodol"},{"issue":"5","key":"866_CR35","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1046\/j.1365-2648.2000.01594.x","volume":"32","author":"GM Higginbottom","year":"2000","unstructured":"Higginbottom GM. Heart health-associated health beliefs and behaviours of adolescents of African and African caribbean descent in two cities in the United Kingdom. J Adv Nurs. 2000;32(5):1234\u201342.","journal-title":"J Adv Nurs"},{"key":"866_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13690-020-0391-8","volume":"78","author":"LA Wozniak","year":"2020","unstructured":"Wozniak LA, Johnson JA, Eurich DT. Working towards a better understanding of type 2 diabetes care organization with first nations communities: a qualitative assessment. Arch Public Health Arch Belg Sante Publique. 2020;78:7.","journal-title":"Arch Public Health Arch Belg Sante Publique"},{"issue":"1","key":"866_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12913-024-12050-4","volume":"25","author":"EM Salmi","year":"2025","unstructured":"Salmi EM, Basile FW, Khan FA, Watt L, Song R, Bijker EM. Facilitators and barriers affecting the implementation of e-health for chronic respiratory diseases in remote settings: a qualitative evidence synthesis. BMC Health Serv Res. 2025;25(1):19.","journal-title":"BMC Health Serv Res"},{"key":"866_CR38","doi-asserted-by":"publisher","first-page":"1494234","DOI":"10.3389\/fmed.2024.1494234","volume":"11","author":"M Bredehorst","year":"2024","unstructured":"Bredehorst M, Gonz\u00e1lez-Gonz\u00e1lez AI, Sch\u00fcrmann L, Firmansyah D, Muth C, Haasenritter J, et al. Recommendations for the primary prevention of atherosclerotic cardiovascular disease in primary care: a systematic guideline review. Front. Med. 2024;11:1494234.","journal-title":"Front. Med"},{"issue":"9","key":"866_CR39","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.healthpol.2021.07.008","volume":"125","author":"A Modigh","year":"2021","unstructured":"Modigh A, Sampaio F, Moberg L, Fredriksson M. The impact of patient and public involvement in health research versus healthcare: a scoping review of reviews. Health Policy. 2021;125(9):1208\u201321.","journal-title":"Health Policy"},{"key":"866_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40900-018-0093-3","volume":"4","author":"M Chalasani","year":"2018","unstructured":"Chalasani M, Vaidya P, Mullin T. Enhancing the incorporation of the patient\u2019s voice in drug development and evaluation. Res Involv Engagem. 2018;4:10.","journal-title":"Res Involv Engagem"},{"key":"866_CR41","doi-asserted-by":"publisher","first-page":"100206","DOI":"10.1016\/j.chbr.2022.100206","volume":"7","author":"MJ Wu","year":"2022","unstructured":"Wu MJ, Zhao K, Fils-Aime F. Response rates of online surveys in published research: a meta-analysis. Comput Hum Behav Rep. 2022;7:100206.","journal-title":"Comput Hum Behav Rep"},{"issue":"6","key":"866_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/NNR.0000000000000690","volume":"72","author":"KM L\u2019Ecuyer","year":"2023","unstructured":"L\u2019Ecuyer KM, Subramaniam DS, Swope C, Lach HW. An integrative review of response rates in nursing research utilizing online surveys. Nurs Res. 2023;72(6):471\u201380.","journal-title":"Nurs Res"},{"key":"866_CR43","doi-asserted-by":"crossref","unstructured":"Meyer VM, Benjamens S, Moumni ME, Lange JFM, Pol RA. Global overview of response rates in patient and health care professional surveys in surgery: a systematic review. Ann Surg. 2022;275(1):e75\u201381.","DOI":"10.1097\/SLA.0000000000004078"},{"key":"866_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40545-019-0175-0","volume":"12","author":"MA Mes","year":"2019","unstructured":"Mes MA, Chan AHY, Wileman V, Katzer CB, Goodbourn M, Towndrow S, et al. Patient involvement in questionnaire design: tackling response error and burden. J Pharm Policy Pract. 2019;12:17.","journal-title":"J Pharm Policy Pract"},{"key":"866_CR45","doi-asserted-by":"publisher","first-page":"104058","DOI":"10.1016\/j.ijnurstu.2021.104058","volume":"123","author":"R Sammut","year":"2021","unstructured":"Sammut R, Griscti O, Norman IJ. Strategies to improve response rates to web surveys: a literature review. Int J Nurs Stud. 2021;123:104058.","journal-title":"Int J Nurs Stud"},{"issue":"12","key":"866_CR46","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/MLR.0000000000001784","volume":"60","author":"R Anhang Price","year":"2022","unstructured":"Anhang Price R, Quigley DD, Hargraves JL, Sorra J, Becerra-Ornelas AU, Hays RD, et al. A systematic review of Strategies to enhance response rates and representativeness of patient experience surveys. Med Care. 2022;60(12):910\u201318.","journal-title":"Med Care"}],"container-title":["Research Involvement and Engagement"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40900-026-00866-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40900-026-00866-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40900-026-00866-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:32:31Z","timestamp":1781641951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40900-026-00866-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["866"],"URL":"https:\/\/doi.org\/10.1186\/s40900-026-00866-9","relation":{},"ISSN":["2056-7529"],"issn-type":[{"value":"2056-7529","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was not required because the research was non-interventional, and the survey questions did not cover health data. Data were collected anonymously, and the collected data did not allow for backward identification of respondents. Completion of the anonymous survey was used as implied consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}